Clinical Trials
23 trialsNCT01004796 2016-02-29
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
National Cancer Institute (NCI)
Unknown
NCT00415298 2014-01-10
AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00553124 2014-01-10
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00671476 2014-01-10
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
National Cancer Institute (NCI)
Phase NA Unknown
NCT00717587 2014-01-10
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00463034 2013-12-18
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
National Cancer Institute (NCI)
Unknown
NCT00898690 2013-12-18
Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer
National Cancer Institute (NCI)
Unknown
NCT00897039 2013-09-20
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Unknown
NCT00360945 2013-09-17
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00625625 2013-09-17
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00082979 2013-08-26
Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00083018 2013-08-26
Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00899262 2013-08-26
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
National Cancer Institute (NCI)
Unknown
NCT00445783 2013-08-12
Study of Families With Melanoma
National Cancer Institute (NCI)
Unknown
NCT00897481 2013-08-12
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
National Cancer Institute (NCI)
Unknown
NCT00989690 2013-08-12
Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01118039 2013-08-07
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00897065 2013-07-10
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
National Cancer Institute (NCI)
Unknown
NCT00471484 2011-06-22
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01150682 2011-04-29
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
National Cancer Institute (NCI)
Unknown
NCT00357617 2010-12-24
Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT01074398 2010-02-24
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
National Cancer Institute (NCI)
Unknown
NCT00801385 2009-08-25
Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy
National Cancer Institute (NCI)
Phase 2 Unknown